Published in J Invest Dermatol on March 01, 1990
Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest (1992) 1.45
Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest (1997) 1.27
Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am J Pathol (1993) 1.08
Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments. Future Med Chem (2009) 1.05
Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol (1998) 0.98
Keratinocyte Migration and a Hypothetical New Role for Extracellular Heat Shock Protein 90 Alpha in Orchestrating Skin Wound Healing. Adv Wound Care (New Rochelle) (2015) 0.84
Ras-transfection up-regulated HaCaT cell migration: inhibition by Marimastat. Clin Exp Metastasis (1999) 0.81
Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT- and HaCaT-ras-transfected cell lines. Clin Exp Metastasis (2003) 0.79
Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry (1977) 2.39
Collagenase production by human skin fibroblasts. Biochem Biophys Res Commun (1975) 2.12
Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol (1988) 2.00
Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem (1983) 1.89
Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med (1984) 1.80
Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci U S A (1991) 1.66
Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci U S A (1986) 1.63
Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol (1984) 1.61
Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. JAMA (1992) 1.60
Nck/Dock: an adapter between cell surface receptors and the actin cytoskeleton. Oncogene (2001) 1.57
Interactions of basement membrane components. Biochim Biophys Acta (1983) 1.57
Congenital localized absence of the skin as a manifestation of epidermolysis bullosa. Arch Dermatol (1992) 1.51
Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J Biol Chem (1983) 1.49
Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol (1992) 1.48
Human skin fibroblast collagenase: chemical properties of precursor and active forms. Biochemistry (1978) 1.47
Laminin inhibits human keratinocyte migration. J Cell Physiol (1988) 1.46
The North American experience with photopheresis. Ther Apher (1999) 1.42
Hailey-Hailey disease is not allelic to Darier's disease. J Invest Dermatol (1994) 1.40
Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin. Biochemistry (1983) 1.39
Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGF-alpha) relative to epidermal growth factor (EGF). J Invest Dermatol (1996) 1.39
Characterization of cellular elements in healed cultured keratinocyte autografts used to cover burn wounds. Arch Dermatol (1990) 1.39
A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. J Biol Chem (1979) 1.37
Human skin fibroblast collagenase: interaction with substrate and inhibitor. Coll Relat Res (1985) 1.37
Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin. J Biol Chem (1997) 1.37
Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells. Exp Cell Res (1983) 1.36
Calcium-induced assembly of adherens junctions in keratinocytes. J Cell Biol (1987) 1.36
Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol (1999) 1.34
Epidermal growth factor receptor number decreases during rat liver regeneration. J Clin Invest (1981) 1.32
Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol (1998) 1.31
Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest (1997) 1.27
Epidermal growth factor (EGF) promotes human keratinocyte locomotion on collagen by increasing the alpha 2 integrin subunit. Exp Cell Res (1993) 1.24
Nckbeta adapter regulates actin polymerization in NIH 3T3 fibroblasts in response to platelet-derived growth factor bb. Mol Cell Biol (2000) 1.24
A model of cell cycle control: sequential events regulated by growth factors. Mol Cell Endocrinol (1983) 1.23
EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int J Dev Biol (1991) 1.22
Diff-Quik stain for Tzanck smears. J Am Acad Dermatol (1985) 1.21
Human keratinocyte locomotion: the effect of selected cytokines. J Invest Dermatol (1992) 1.21
Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: development of an experimental in vivo model. J Invest Dermatol (1992) 1.20
Differential proteolytic susceptibility of laminin alpha and beta subunits. Arch Biochem Biophys (1982) 1.16
Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest (1993) 1.16
Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis. Proc Natl Acad Sci U S A (1982) 1.16
Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sci U S A (1985) 1.15
Laminin-5 inhibits human keratinocyte migration. Exp Cell Res (1997) 1.15
The gelatinolytic activity of human skin fibroblast collagenase. J Biol Chem (1982) 1.12
Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies. Arch Dermatol (1995) 1.12
Spreading and enhanced motility of human keratinocytes on fibronectin. J Invest Dermatol (1985) 1.12
Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression. Mol Biol Cell (2000) 1.11
NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. J Invest Dermatol (1999) 1.10
Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen. J Biol Chem (1986) 1.10
Singlet oxygen may mediate the ultraviolet A-induced synthesis of interstitial collagenase. J Invest Dermatol (1995) 1.10
The large non-collagenous domain (NC-1) of type VII collagen is amino-terminal and chimeric. Homology to cartilage matrix protein, the type III domains of fibronectin and the A domains of von Willebrand factor. Hum Mol Genet (1992) 1.09
Cutaneous wound healing: a model for cell-matrix interactions. J Am Acad Dermatol (1985) 1.09
Re-epithelialization. Human keratinocyte locomotion. Dermatol Clin (1993) 1.08
Integrin receptors and RGD sequences in human keratinocyte migration: unique anti-migratory function of alpha 3 beta 1 epiligrin receptor. J Invest Dermatol (1992) 1.08
Cutaneous toxicity of bleomycin therapy. Arch Dermatol (1973) 1.08
Aging and cross-linking of skin collagen. Biochem Biophys Res Commun (1988) 1.08
Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Arch Biochem Biophys (1996) 1.07
HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI. Int J Cancer (1998) 1.06
Epidermolysis bullosa acquisita antigen, a major cutaneous basement membrane component, is synthesized by human dermal fibroblasts and other cutaneous tissues. J Invest Dermatol (1986) 1.05
Differentiation of a human leukemia cell line and expression of collagenase inhibitor. Proc Natl Acad Sci U S A (1985) 1.05
Human nevocellular nevus cells are surrounded by basement membrane components. Immunohistologic studies of human nevus cells and melanocytes in vivo and in vitro. Lab Invest (1988) 1.04
Induction of keratinocyte IL-8 expression and secretion by IgG autoantibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol (2000) 1.03
Alteration of epidermal growth factor-dependent phosphorylation during rat liver regeneration. Proc Natl Acad Sci U S A (1982) 1.03
Coregulation of collagenase and collagenase inhibitor production by phorbol myristate acetate in human skin fibroblasts. Arch Biochem Biophys (1985) 1.03
Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor. J Biol Chem (1994) 1.02
Epidermolysis bullosa acquisita--a pemphigoid-like disease. J Am Acad Dermatol (1984) 0.99
The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies. J Biol Chem (2001) 0.99
Burn wounds resurfaced by cultured epidermal autografts show abnormal reconstitution of anchoring fibrils. JAMA (1988) 0.99
Tyrosine phosphorylation of human keratinocyte beta-catenin and plakoglobin reversibly regulates their binding to E-cadherin and alpha-catenin. J Invest Dermatol (2001) 0.99
A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1985) 0.98
Characteristics of the action of human skin fibroblast collagenase on fibrillar collagen. J Biol Chem (1980) 0.98
Structure and function of basement membrane. J Invest Dermatol (1982) 0.98
Epidermolysis bullosa acquisita: update and review. Clin Dermatol (2001) 0.98
Localization of the alpha 3 (V) chain of type V collagen in human skin. J Invest Dermatol (1987) 0.97
Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol (1997) 0.97
Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts. Arch Biochem Biophys (1995) 0.96
Elevated levels of human collagenase inhibitor in blister fluids of diverse etiology. J Invest Dermatol (1986) 0.96
Interleukin-1 alpha stimulates keratinocyte migration through an epidermal growth factor/transforming growth factor-alpha-independent pathway. J Invest Dermatol (1995) 0.95
Mechanism of human keratinocyte migration on fibronectin: unique roles of RGD site and integrins. J Cell Physiol (1992) 0.95
Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol (1997) 0.95
Ultraviolet A irradiation upregulates type VII collagen expression in human dermal fibroblasts. J Invest Dermatol (1997) 0.94
Adult human keratinocytes migrating over nonviable dermal collagen produce collagenolytic enzymes that degrade type I and type IV collagen. J Invest Dermatol (1986) 0.94
Platelet-derived growth factor modulates epidermal growth factor receptors by a mechanism distinct from that of phorbol esters. Proc Natl Acad Sci U S A (1986) 0.94
Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures. J Clin Invest (1982) 0.94
Mechanisms of human skin cell motility. Histol Histopathol (2004) 0.93
Epidermolysis bullosa acquisita antigen is synthesized by human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun (1985) 0.93
Bleomycin in the treatment of recalcitrant warts. J Am Acad Dermatol (1983) 0.93
Partial characterization of matrix-associated serine protease inhibitors from human skin cells. J Invest Dermatol (1995) 0.93
An adherens junction protein is a member of the family of lactose-binding lectins. J Biol Chem (1994) 0.92
Production of soluble and cell-associated fibronectin by cultured keratinocytes. J Invest Dermatol (1984) 0.92
Hydrogen peroxide inhibits human keratinocyte migration. Dermatol Surg (1996) 0.91